Perfil
David Kao is Vice President-Regulatory Affairs at Inhibrx Biosciences, Inc. since 2021.
Former positions include Vice President-Regulatory Affairs at Sanofi AATD, Inc. from 2021 to 2024 and Head-Development Program at Bristol Myers Squibb Co. Education includes undergraduate studies at Rutgers State University of New Jersey, a doctorate from Shenandoah University, and an MBA from Rutgers Business School.
Cargos activos de David Kao
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de David Kao.
| Empresas | Cargo | Fin |
|---|---|---|
| INHIBRX, INC. | Consejero General | 30/05/2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formación de David Kao.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenandoah University
Shenandoah University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers Business School
Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibrx, Inc.
Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
- Bolsa de valores
- Insiders
- David Kao
















